Status:
COMPLETED
ArterX Surgical Sealant, A Randomized Prospective Multicenter Trial
Lead Sponsor:
Tenaxis Medical, Inc.
Conditions:
Vascular Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a prospective, multi-center randomized, controlled study. The study is designed to assess the safety effectiveness of the ArterX Vascular Sealant compared to the control group in the open surg...
Detailed Description
To evaluate, during open vascular surgery, the safety and effectiveness of the ArterX™ Vascular Sealant when applied prophylactically. Application will be at synthetic vascular graft or patch to nativ...
Eligibility Criteria
Inclusion
- Subject must meet all of the following criteria to be eligible for treatment in the Study:
- The subject must be equal or greater than 18 years old.
- The subject must be scheduled for the surgical placement of a synthetic (i.e., PTFE/Dacron) vascular graft or patch for large vessel repair/arterial reconstruction/hemodialysis access/arteriotomy.
- The subject has no child bearing potential or has a negative serum or urine pregnancy test within 7 days of the index procedure.
- The subject is willing and able to be contacted for the follow up visits at 6 weeks (± 7 days) and 3 months (± 7 days).
- The subject or guardian must provide written informed consent using a form that is reviewed and approved by the IRB.
Exclusion
- Subjects will be excluded from the Study if any of the following criteria are met:
- The subject has a known hypersensitivity or contraindication to heparin, bovine or seafood products.
- The subject has a history of bleeding diathesis or coagulopathy, or will refuse blood transfusions.
- The subject is currently enrolled in this, or another investigational device or drug trial (IDE or IND) that has not completed the required follow-up period. Note: Extended follow-up trials for products that were investigational but are currently commercially available are not considered investigational trials.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT00759681
Start Date
September 1 2008
End Date
March 1 2010
Last Update
January 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Greenville Memorial Hospital
Greenville, South Carolina, United States, 29615